These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

16 related articles for article (PubMed ID: 38722875)

  • 1. Correction: Specific transfection of inflamed brain by macrophages: A new therapeutic strategy for neurodegenerative diseases.
    Haney MJ; Zhao Y; Harrison EB; Mahajan V; Ahmed S; He Z; Suresh P; Hingtgen SD; Klyachko NL; Mosley RL; Gendelman HE; Kabanov AV; Batrakova EV
    PLoS One; 2024; 19(7):e0306688. PubMed ID: 38954693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal β-Amyloid Clearance Pathways and Slows Progression of Alzheimer's Like-Disease in PS1-APP Mice.
    Hickman SE; Allison EK; Coleman U; Kingery-Gallagher ND; El Khoury J
    Front Immunol; 2019; 10():2780. PubMed ID: 31849963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Beneficial Effects of Combining Anti-Aβ Antibody NP106 and Curcumin Analog TML-6 on the Treatment of Alzheimer's Disease in APP/PS1 Mice.
    Su IJ; Hsu CY; Shen S; Chao PK; Hsu JT; Hsueh JT; Liang JJ; Hsu YT; Shie FS
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proteomics reveals that PEA15 regulates astroglial Aβ phagocytosis in an Alzheimer's disease mouse model.
    Lv J; Ma S; Zhang X; Zheng L; Ma Y; Zhao X; Lai W; Shen H; Wang Q; Ji J
    J Proteomics; 2014 Oct; 110():45-58. PubMed ID: 25108202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell therapy: a safe and efficacious therapeutic treatment for Alzheimer's disease in APP+PS1 mice.
    Nabar NR; Yuan F; Lin X; Wang L; Bai G; Mayl J; Li Y; Zhou SF; Wang J; Cai J; Cao C
    PLoS One; 2012; 7(12):e49468. PubMed ID: 23226497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Cell Therapy: A Safe and Efficacious Therapeutic Treatment for Alzheimer's Disease in APP+PS1 Mice.
    Nabar NR; Yuan F; Lin X; Wang L; Bai G; Mayl J; Li Y; Zhou SF; Wang J; Cai J; Cao C
    PLoS One; 2024; 19(5):e0303619. PubMed ID: 38722875
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.